Up Next
Back to Show
American Black Journal
FDA approves new gene therapies for sickle cell disease
Host Stephen Henderson examines the groundbreaking new gene therapies approved by the U.S. Food and Drug Administration as a treatment option for sickle cell disease. Dr. Melissa Creary, assistant professor at the University of Michigan’s School of Public Health, sits down with Henderson to talk about the pros, cons and possible barriers of the new gene-editing therapy.
Support Provided By
26:46
The Black Church in Detroit discusses the Mideast conflict and interfaith relationships.
26:46
Opera tenor George Shirley, Omega Psi Phi Detroit’s 100th and MEDF’s 30th anniversary.
26:46
Ruth E. Carter’s Afrofuturism exhibit and Dance Theatre of Harlem’s Detroit performances.
26:46
Blue Bird Inn jazz club, World Mental Health Day, social media and teens' mental health.
26:46
The barriers of re-entry for the wrongfully convicted and The Yunion’s 20th anniversary.
26:46
The impact of technology and artificial intelligence in the Black Church and Caleb’s Kids.
26:46
DPS Community District/Black Reading Month
26:46
The “Black Church in Detroit” explores the current state of civil rights 60 years later.
25:00
Motown Records captures Dr. King’s speeches in Detroit, and a tribute to Motown’s legacy.
25:00
Artist Brittini Ward unveils the inspiration behind the 2023 Detroit Jazz Festival poster.
26:46
Focus: HOPE’s seniors food program, Maria Rosario Jackson, Detroit’s Nigerian community.
26:46
The Michigan Diversity Council’s annual summit and summer reading with Brilliant Detroit.